(Q33582039)

28 July 2017

title

Pharmacological treatments in pathological gambling (English)

1 reference

28 July 2017

1 reference

1 reference

Brian L Odlaug

2

0 references

author name string

Jon E Grant

series ordinal

1

1 reference

28 July 2017

Liana R N Schreiber

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 February 2014

1 reference

British Journal of Clinical Pharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

77

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

375-381

1 reference

Evidence-based pharmacological treatment of substance use disorders and pathological gambling

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Psychopharmacological treatment in pathological gambling: a critical review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Disordered (pathologic or problem) gambling and axis I psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Changes of functional MRI findings in a patient whose pathological gambling improved with fluvoxamine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

An empirical typology of lifetime and current gambling behaviors: association with health status of older adults.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Predicting response to opiate antagonists and placebo in the treatment of pathological gambling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Animal models and brain circuits in drug addiction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam Era Twin Registry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Sertraline treatment of pathological gambling: a pilot study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Amphetamine Primes Motivation to Gamble and Gambling-Related Semantic Networks in Problem Gamblers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

21 June 2018

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Pathological gambling: addiction or compulsion?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Fluvoxamine in the treatment of compulsive buying

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

21 June 2018

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Diagnosis, neurobiology, and treatment of pathological gambling.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Gambling problems and health functioning in individuals receiving disability.

21 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Low platelet monoamine oxidase activity in pathological gambling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

A family study of pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Effects of acute modafinil on cognition in trichotillomania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

Opioid Antagonists in the Treatment of Impulse-Control Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2012.04457.X

A double-blind, placebo-controlled trial of topiramate for pathological gambling

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Quality of life and family history in pathological gambling.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

A pilot placebo-controlled study of fluvoxamine for pathological gambling.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Demographic and clinical features of 131 adult pathological gamblers

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

Opioid antagonists in the treatment of impulse-control disorders.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4014021

A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling

31 October 2018

1 reference

12 December 2020

Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study

1 reference

12 December 2020

Treatment of pathological gambling with clomipramine

1 reference

12 December 2020

Quality of life in kleptomania and pathological gambling

1 reference

12 December 2020

Gambling and suicidality in treatment-seeking pathological gamblers

1 reference

12 December 2020

10.1111/J.1365-2125.2012.04457.X

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference